DrugPatentWatch Database Preview
Profile for Austria Patent: 380194
US Patent Family Members and Approved Drugs for Austria Patent: 380194
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Aug 3, 2021 | Glaxo Grp Ltd | BREO ELLIPTA | fluticasone furoate; vilanterol trifenatate |
➤ Try a Free Trial | Aug 3, 2021 | Glaxosmithkline | TRELEGY ELLIPTA | fluticasone furoate; umeclidinium bromide; vilanterol trifenatate |
➤ Try a Free Trial | Aug 3, 2021 | Glaxo Grp Ltd | BREO ELLIPTA | fluticasone furoate; vilanterol trifenatate |
➤ Try a Free Trial | Aug 3, 2021 | Glaxosmithkline | TRELEGY ELLIPTA | fluticasone furoate; umeclidinium bromide; vilanterol trifenatate |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |